Task: Answer Verification
Input (English): Question: Are subjects with molecularly defined familial hypercholesterolemia or familial defective apoB-100 being adequately treated?
Answer: The majority of FH/FDB subjects are being diagnosed late in life and are not being adequately treated. In order to prevent them from contracting premature coronary heart disease, it is key that levels of LDL cholesterol are normalized from a young age and that sufficient doses of lipid-lowering drugs are being used.
Output (English): no